Unequal Burden: Understanding the Roots of Disparities in Cancer Care


Karen Peterson, Patient Advocate
Founder & Chief Patient Advocate, Karen's Club, New York, NY
Karen Peterson, Patient Advocate

Karen is a founding member of the Patient Community Council at Foundation Medicine, a consultant for Blue Note Therapeutics, and a Cancer Research Institute – Immuno Advocate. Karen was the featured patient speaker at the Biden Cancer Initiative’s 2019 presentation at ASCO, and the 2020 inaugural AACR Cancer Disparities Progress Report presented to Congress. Her inspiring story has been shared with Cure, Essence, Health, and People magazines as well as ABC Radio Network’s “Perspective” and “The Today Show.”

Karen successfully completed the exclusive 2021 Robin Hood/Blue Ridge Labs Fellowship Program, where she co-created the advocacy platform Karen’s Club, which educates, informs, and supports patients of color around clinical trials. Karen’s Club builds trust, credibility, and health literacy by providing a free 1:1 consultation with Patient Advisors of color who have clinical trial experience and can actually speak and describe what participating in a medical study is like. In addition, Karen’s Club provides educational webinars with top clinical researchers addressing all things clinical trials. Lastly, Karen’s Club provides health equity and engagement training for patient educators and medical providers.

Caregivers, Patients, and Researchers can find out more information about the offerings by visiting karensclub.org

Bradley Carthon, MD, PhD
Associate Professor, GU Medical Oncology
Section Chief, Hematology Oncology Winship Midtown
Interim Director, Division of Medical Oncology, Winship Cancer Institute, Emory University Hospital, Atlanta, GA
Bradley Carthon, MD, PhD

Dr. Carthon graduated from Hampton University in 1996 with honors as a Biology major and Chemistry minor. He went on to receive his MD and PhD degrees from Harvard Medical School and Harvard University in 2005, where he studied the roles of cell cycle proteins in mammary gland and breast cancer development. He remained in Boston for his residency in Internal Medicine at the Massachusetts General Hospital.

Dr. Carthon then did his Medical Oncology Fellowship training at the University of Texas M.D. Anderson Cancer Hospital. While at M.D. Anderson, he chose to focus on Genitourinary Medical Oncology and worked on Caveolin-1 as a biomarker of prostate cancer bone metastases.

Dr. Carthon joined Winship Cancer Institute of Emory University in Atlanta in 2011. He serves as a member of the Genitourinary Oncology Group and prior was a member of the Phase I Early Discovery Unit. His interest is in novel therapeutic targets and clinical trials that utilize treatment combinations for patients with prostate, bladder, testicular, and kidney cancers, as well a broad array of solid tumors. He is principal investigator on numerous genitourinary and phase I clinical trials. He is currently Associate Professor of GU Medical Oncology and serves as Chief of Hematology Oncology at Emory Winship Midtown. He is currently serving as Interim Director, Division of Medical Oncology.

Dr. Carthon has served as an ASCO University Faculty member and as a member of the ASCO PSA Screening Task Force. He is currently Track Leader and member of the 2022 ASCO Annual Meeting Education Committee for Prostate Cancer, the 2022 ASCO Annual Meeting Scientific Program Committee, and is a member of the NRG Cooperative Group Early Phase Clinical Trials Safety Committee. He has an interest in health disparities and has served as Chair of the Winship Cancer Institute Health Disparities, Health Literacy and Minority Accrual Committee.

Manali I. Patel, MD, MPH, MS
Assistant Professor, Division of Oncology
Affiliate Faculty, Department of Health Policy
Stanford University School of Medicine, Stanford, CA
Staff Oncologist, VA Palo Alto Health Care System, Palo Alto, CA
Manali I. Patel, MD, MPH, MS

Dr. Manali I. Patel is a Thoracic Oncologist and Health Services Researcher at the Stanford University School of Medicine and the Veterans Affairs Palo Alto Health Care System. Dr. Patel obtained her MD and MPH at UNC-Chapel Hill and completed her Internal Medicine residency, fellowship in Hematology and Oncology, and Master of Science in Health Services Research at Stanford University. Dr. Patel?s research involves evaluating systems-level and social factors that influence disparities in cancer and value-based care delivery. Her expertise lies in designing, implementing, and evaluating new models of cancer care delivery with academic, community, and VA oncology practices aimed to improve patient experiences with care, clinical outcomes, and reduce unwanted health care utilization and health disparities.

Statement of Need

Inequities in cancer screenings, care, and outcomes stem primarily from the social determinants of health (SDoH) and the barriers they create. These inequities impact racial and ethnic historically marginalized groups, adolescents and young adults, older people, residents of specific geographic locations (for example, populations from rural areas), members of the LGBTQIA+ community, and individuals with low socioeconomic status, low health literacy, and no or poor health insurance. People from these groups are less likely to receive recommended cancer screenings and more likely to be diagnosed with cancer at later stages, with higher disease burden and poorer outcomes. Nearly half of cancer cases and cancer-related deaths are caused by modifiable risk factors, primarily from SDoH and environmental factors that disproportionately hinder underserved populations. Moreover, members of these groups are less likely to be included in research studies or receive standard of care. However, when these inequities are reduced or eliminated, these individuals often have better outcomes than those not experiencing inequities.

In this OnDemand webcast, expert faculty will discuss the inequities that impact members of historically marginalized groups and the factors that contribute to these disparities. They will review the groups impacted, the role social determinants of health play, and strategies to reduce or eliminate disparities for these communities, leading to better access to screenings, diagnosis, treatment, and outcomes.


Learning Objectives

At the end of this CME/CE activity, participants should be able to recognize factors contributing to health disparities in the cancer care continuum and their impact on patient care.

Financial Support

Supported by educational grants from Bristol Myers Squibb and Merck Sharpe & Dohme Corp.

Target Audience

Physicians, PAs, nurse practitioners, nurses, nurse navigators, pharmacists, social workers, and case managers specializing in oncology, emergency medicine and/or primary care

Credit Information

Physicians (ACCME) .75

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Outfitters, LLC, designates this enduring activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists/Pharmacy Tech (ACPE) .75

This application-based activity is approved for 0.75 contact hour (0.075 CEUs) of continuing pharmacy credit.
Activity UAN: JA0007185-0000-22-080-H01-P

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit  from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurses (ANCC)

This activity is designated for 1.0 contact hour.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.


CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until the expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Ms. Peterson reports the following financial relationships: Patient Advisory Board: Blue Note Therapeutics and Foundation Medicine, Inc.

Dr. Carthon reports the following financial relationships: Advisory Board: Astellas Pharma US, Inc./Pfizer Inc. and Bristol Myers Squibb Company; Consultant: Gilead Research Scholars Program; Research Support: Alkermes; Astellas Pharma US, Inc.; Bristol Myers Squibb Company; Calithera Biosciences, Inc.; Clovis Oncology; ESSA Pharma; and Immunomedics, Inc.

Dr. Patel reports no financial relationships.

The following peer reviewer and CME Outfitters staff have no financial relationships:

  • Michael Franks, APRN, AGACNP-BC, FNP-BC (peer reviewer)
  • David Modrak, PhD (planning committee)
  • Kathleen Blake, PhD (planning committee)
  • Thomas Mitchell (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.


NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-22-080-H01-P.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).


Unequal Burden: Understanding the Roots of Disparities in Cancer Care
Event Date: 06/29/2022